See every side of every news story
Published loading...Updated

Biden Officials Knew About, Downplayed Risks From COVID-19 Vaccines, Senate Report Claims

  • On May 22, 2025, the FDA ordered Pfizer and Moderna to update COVID-19 vaccine labels to warn about rare heart inflammation in males aged 16 to 25.
  • This directive followed new 2023 data and safety monitoring showing the highest myocarditis and pericarditis risk in young males after mRNA vaccines.
  • The label changes include Pfizer's Comirnaty and Moderna's Spikevax and note about 38 cases per million doses in this group, with MRIs showing improvement over time.
  • FDA spokesperson Andrew Nixon emphasized the agency’s commitment to “radical transparency” while ongoing studies seek to clarify long-term heart effects from vaccine-associated myocarditis.
  • Both companies have 30 days to respond, highlighting ongoing efforts to balance transparent safety communication with sustaining public trust in COVID-19 vaccinations.
Insights by Ground AI
Does this summary seem wrong?

79 Articles

All
Left
4
Center
7
Right
44
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 80% of the sources lean Right
80% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The National Desk broke the news in on Wednesday, May 21, 2025.
Sources are mostly out of (0)